Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer

J Clin Oncol. 2008 Mar 1;26(7):1186-7; author reply 1187-8. doi: 10.1200/JCO.2007.15.1951.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Female
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic
  • Genomics*
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / genetics*
  • Prognosis

Substances

  • Antineoplastic Agents